pharma

Pharma companies are getting more and more open about their digital health initiatives, which has given MobiHealthNews more opportunities this quarter than usual to chronicle pharma’s efforts around adherence, clinical trials, and the burgeoning world of digital therapeutics.

Medication management and adherence app maker Medisafe has announced a partnership with Boehringer Ingelheim following a successful pilot.

Benchling, which offers a software suite for improving collaboration and productivity among life sciences and biotech researchers, has raised $14.

Cambridge, Massachusetts-based sensor maker MC10, known for its flexible and stretchable electronics, has received its first FDA 510(k) clearance for the BioStamp nPoint system.

Pharma companies have been eying digital health with interest, and the first quarter of 2018 was no exception.

In 2016, we rounded up pharma news in the first, second, and third quarter of the year.

According to a report in Bloomberg, GlaxoSmithKline is in talks with Qualcomm to create a new joint venture to develop medical technology.

One of the biggest ways the changing digital health landscape will affect the pharma industry is that pharma companies increasingly stand to lose control over their own stories, according to a new report from McKinsey & Company, who spoke to 20 thought leaders in various pharma-adjacent sectors.

Bryan Roberts Bryan Roberts, one of Venrock's healthcare-focused investment partners, has some rules of thumb for investing in digital health -- and for what to pass up.

Sixty-six percent of all pharma app downloads in the United States, the United Kingdom, and Germany, were downloads of the top 10 apps according to an infographic recently released by German app company SmartPatient (not to be confused with Roni Zeiger-founded online patient community SmartPatients).